ICD-10-CM Billable Code

Z80.42

Family history of malignant neoplasm of prostate

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code Z80.42 refers to a medical classification indicating a person's family history of malignant tumors of the prostate. Having a family history of prostate cancer can influence an individual's risk factors and screening schedules. This code is used by healthcare professionals to document genetic predispositions that may affect diagnosis, prevention, and management strategies for prostate health.

Causes & Symptoms

Clinical Causes: Genetic factors: inherited gene mutations that increase prostate cancer risk Family history: having first-degree relatives (father, brother, son) diagnosed with prostate cancer Shared environmental exposures: lifestyle or environmental factors shared within families that may contribute to cancer risk

Key Symptoms: Typically, prostate cancer may be asymptomatic in early stages Advanced symptoms may include difficulty urinating, blood in urine or semen, pelvic discomfort, or erectile dysfunction Note: The presence of symptoms depends on disease progression, but family history alone does not cause ongoing symptoms

Diagnostic & Treatment

Diagnosis Path: Diagnosing a familial risk of prostate cancer involves a combination of medical history assessment and screening tests. Healthcare providers may perform the following:

Treatment Protocols: While a family history itself does not require treatment, individuals with increased genetic risk may consider the following strategies under medical guidance:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z80.42 a billable ICD-10 code?
Yes, Z80.42 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z80.42?
Clinical documentation must specify the nature of Family history of malignant neoplasm of prostate and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

neoplasm prostate malignant family